138 related articles for article (PubMed ID: 7488321)
1. Two different inhibitory effects of pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid on adenosine diphosphate-induced human platelet aggregation.
Windscheif U; Radziwon P; Breddin HK; Bäumert HG; Lambrecht G; Mutschler E
Arzneimittelforschung; 1995 Sep; 45(9):994-7. PubMed ID: 7488321
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological evidence for the existence of multiple P2 receptors in the circular muscle of guinea-pig colon.
Zagorodnyuk V; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):122-8. PubMed ID: 9484862
[TBL] [Abstract][Full Text] [Related]
3. Effects of the P2-purinoceptor antagonist, suramin, on human platelet aggregation induced by adenosine 5'-diphosphate.
Hourani SM; Hall DA; Nieman CJ
Br J Pharmacol; 1992 Feb; 105(2):453-7. PubMed ID: 1559134
[TBL] [Abstract][Full Text] [Related]
4. ATP released from astrocytes during swelling activates chloride channels.
Darby M; Kuzmiski JB; Panenka W; Feighan D; MacVicar BA
J Neurophysiol; 2003 Apr; 89(4):1870-7. PubMed ID: 12686569
[TBL] [Abstract][Full Text] [Related]
5. Design and pharmacology of selective P2-purinoceptor antagonists.
Lambrecht G
J Auton Pharmacol; 1996 Dec; 16(6):341-4. PubMed ID: 9131412
[TBL] [Abstract][Full Text] [Related]
6. P2 purinoceptor antagonists inhibit the non-adrenergic, non-cholinergic relaxation of the human colon in vitro.
Benkó R; Undi S; Wolf M; Vereczkei A; Illényi L; Kassai M; Cseke L; Kelemen D; Horváth OP; Antal A; Magyar K; Barthó L
Neuroscience; 2007 Jun; 147(1):146-52. PubMed ID: 17509767
[TBL] [Abstract][Full Text] [Related]
7. Suramin-induced reversal of chronic cerebral vasospasm in experimental subarachnoid hemorrhage.
Kimura H; Meguro T; Badr A; Zhang JH
J Neurosurg; 2002 Jul; 97(1):129-35. PubMed ID: 12134903
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of ADP-induced aggregation by 5-HT in rabbit platelets.
Li BY; Bai Y; Li WH
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):58-62. PubMed ID: 10375761
[TBL] [Abstract][Full Text] [Related]
9. The influence of hypothermia on P2 receptor-mediated responses of frog skeletal muscle.
Ziganshin AU; Kamaliev RR; Grishin SN; Ziganshina LE; Zefirov AL; Burnstock G
Eur J Pharmacol; 2005 Feb; 509(2-3):187-93. PubMed ID: 15733555
[TBL] [Abstract][Full Text] [Related]
10. Complexities of measuring antagonist potency at P2X(7) receptor orthologs.
Hibell AD; Thompson KM; Xing M; Humphrey PP; Michel AD
J Pharmacol Exp Ther; 2001 Mar; 296(3):947-57. PubMed ID: 11181928
[TBL] [Abstract][Full Text] [Related]
11. PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors.
Charlton SJ; Brown CA; Weisman GA; Turner JT; Erb L; Boarder MR
Br J Pharmacol; 1996 Jun; 118(3):704-10. PubMed ID: 8762097
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors).
Evans RJ; Lewis C; Buell G; Valera S; North RA; Surprenant A
Mol Pharmacol; 1995 Aug; 48(2):178-83. PubMed ID: 7544432
[TBL] [Abstract][Full Text] [Related]
13. Ecto-nucleotide pyrophosphatase modulates the purinoceptor-mediated signal transduction and is inhibited by purinoceptor antagonists.
Grobben B; Claes P; Roymans D; Esmans EL; Van Onckelen H; Slegers H
Br J Pharmacol; 2000 May; 130(1):139-45. PubMed ID: 10781009
[TBL] [Abstract][Full Text] [Related]
14. PPADS: an antagonist at endothelial P2Y-purinoceptors but not P2U-purinoceptors.
Brown C; Tanna B; Boarder MR
Br J Pharmacol; 1995 Nov; 116(5):2413-6. PubMed ID: 8581277
[TBL] [Abstract][Full Text] [Related]
15. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
[TBL] [Abstract][Full Text] [Related]
16. Tetrandrine differentially inhibits aggregation and ATP-release of rat platelets.
Chen YY; Kwan CY; Hui SC
Zhongguo Yao Li Xue Bao; 1996 Mar; 17(2):105-8. PubMed ID: 9772654
[TBL] [Abstract][Full Text] [Related]
17. FPL 66096: a novel, highly potent and selective antagonist at human platelet P2T-purinoceptors.
Humphries RG; Tomlinson W; Ingall AH; Cage PA; Leff P
Br J Pharmacol; 1994 Nov; 113(3):1057-63. PubMed ID: 7858849
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation and adenosine diphosphate/adenosine triphosphate receptors: a historical perspective.
Packham MA; Mustard JF
Semin Thromb Hemost; 2005 Apr; 31(2):129-38. PubMed ID: 15852216
[TBL] [Abstract][Full Text] [Related]
19. [Effect of lead and cadmium on platelet aggregation].
López JP; de la Peña A; Baños de MacCarthy G
Arch Inst Cardiol Mex; 1992; 62(4):317-24. PubMed ID: 1417349
[TBL] [Abstract][Full Text] [Related]
20. Evidence that adenosine diphosphate can activate adenylate cyclase via conversion to adenosine in platelet-rich plasma containing magnesium.
Glenn JR; Heptinstall S
Thromb Haemost; 1998 Aug; 80(2):321-5. PubMed ID: 9716160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
